Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
From November 1 this year Significant changes in the drug reimbursement system are coming into force in Poland, which may affect the availability of certain preparations and the costs of treatment. In this article, we will discuss the most important issues related to the new regulations on drug reimbursement, including changes in the reimbursement of over-the-counter drugs, the end of reimbursement of some antidiabetic drugs and the lack of reimbursement of intranasal influenza vaccine and a drug used to treat prostate cancer.
Reimbursement of over-the-counter drugs
From November, patients can expect changes in the reimbursement of over-the-counter drugs. As part of these changes, certain preparations may be reimbursed to a lesser extent or not at all. For many people, especially those with chronic conditions, this may mean higher costs of purchasing necessary medications. It is worth paying attention to the information on packaging and in pharmacies to avoid misunderstandings and additional expenses.
End of reimbursement for some antidiabetic drugs
One of the key points of change is the end of reimbursement of some antidiabetic drugs. People with diabetes may be particularly affected by these changes, as some medicines will no longer be reimbursed or will be reimbursed to a lesser extent. For patients, this means the need to change therapy or incur higher treatment costs. It is worth consulting a doctor to adapt the treatment plan to the new reimbursement conditions.
There is no reimbursement for intranasal influenza vaccine and drugs used to treat prostate cancer
Another important change is the lack of reimbursement for the intranasal influenza vaccine and the drug used to treat prostate cancer. The flu vaccine is especially important in the fall and winter season, when the risk of catching the flu increases. Patients who benefited from reimbursement for this vaccine will now have to bear its full costs. The situation is similar in the case of a drug used to treat prostate cancer. These are changes that can significantly impact some patients’ budgets, so it’s important to be aware of these changes and prepare for them appropriately.
Your suggestions
If you are a patient and have questions or concerns about changes in drug reimbursement, it is always worth consulting your doctor or pharmacist. They can provide you with relevant information and advise you on how to adapt your treatment to the new regulations. Also remember to monitor messages on the websites of the Ministry of Health and the National Health Fund, where current information on this subject is published.
Recommended articles
If you are interested in drug reimbursement and changes in the health care system, we also recommend reading other articles on this topic. Knowing this can be crucial to staying healthy and saving on medications. Let’s stay informed and take care of our health.